StockDrifts LogoStockDrifts

Nantahala Capital Management 13F Portfolio ยท Wilmot Harkey

Portfolio Manager
Wilmot Harkey
Performance
+21.54% (2026 Q2)
AUM (13F)
$3.00B
# of Holdings
129
Performance Rank
Allocation (Top 20)
44.22%
Latest filing
Q2 2026

Nantahala Capital Management LLC Holdings Map

Top 50 Nantahala Capital Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
TBBK
BANCORP INC DEL
4.72%1.24M$77.7M
-10.18%(-140.57K)
2025-Q2: 968.5K shares2025-Q3: 852.3K shares2025-Q4: 1.07M shares2026-Q1: 1.38M shares2026-Q2: 1.24M shares
$53.51(+30.21%)
2026-06-30
BVS
BIOVENTUS INC
3.44%6.00M$56.6M
-1.99%(-122.12K)
2025-Q2: 5.28M shares2025-Q3: 5.81M shares2025-Q4: 6.05M shares2026-Q1: 6.12M shares2026-Q2: 6.00M shares
$4.97(+186.64%)
2026-06-30
HGV
HILTON GRAND VACATIONS INC
3.29%1.03M$54.1M
-31.74%(-480.49K)
2025-Q2: 1.99M shares2025-Q3: 1.67M shares2025-Q4: 1.56M shares2026-Q1: 1.51M shares2026-Q2: 1.03M shares
$37.85(+21.34%)
2026-06-30
SVRA
SAVARA INC
2.61%6.98M$43.0M
-5.01%(-367.97K)
2025-Q2: 8.33M shares2025-Q3: 8.78M shares2025-Q4: 7.34M shares2026-Q1: 7.34M shares2026-Q2: 6.98M shares
$3.96(+35.95%)
2026-06-30
ETON
ETON PHARMACEUTICALS INC
2.59%1.18M$42.6M
+0.00%(+0)
2025-Q2: 1.18M shares2025-Q3: 1.18M shares2025-Q4: 1.18M shares2026-Q1: 1.18M shares2026-Q2: 1.18M shares
$4.67(+1160.02%)
2026-06-30
AMRX
AMNEAL PHARMACEUTICALS INC
2.39%2.27M$39.3M
-20.23%(-575.36K)
2025-Q2: 4.37M shares2025-Q3: 4.22M shares2025-Q4: 2.45M shares2026-Q1: 2.84M shares2026-Q2: 2.27M shares
$5.93(+205.98%)
2026-06-30
EOLS
EVOLUS INC
2.36%5.60M$38.9M
-12.15%(-774.84K)
2025-Q2: 4.20M shares2025-Q3: 5.73M shares2025-Q4: 5.82M shares2026-Q1: 6.38M shares2026-Q2: 5.60M shares
$9.16(-10.50%)
2026-06-30
AVTX
AVALO THERAPEUTICS INC
2.09%1.86M$34.4M
+50.79%(+627.25K)
2025-Q2: 995.0K shares2025-Q3: 1.24M shares2025-Q4: 1.24M shares2026-Q1: 1.24M shares2026-Q2: 1.86M shares
$10.67(+83.55%)
2026-06-30
LBRX
LB PHARMACEUTICALS INC
2.08%1.05M$34.2M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 675.0K shares2025-Q4: 675.0K shares2026-Q1: 1.05M shares2026-Q2: 1.05M shares
$18.54(+157.65%)
2026-06-30
AVR
ANTERIS TECHNOLOGIES GLOBAL
2.03%3.38M$33.3M
-38.83%(-2.15M)
2025-Q2: 1.69M shares2025-Q3: 1.92M shares2025-Q4: 2.53M shares2026-Q1: 5.53M shares2026-Q2: 3.38M shares
$5.25(+79.00%)
2026-06-30

About Nantahala Capital Management LLCโ€™s portfolio

Nantahala Capital Management LLC reports $3.00B in US-listed equity holdings across 129 positions in its most recent 13F filing. Its largest disclosed positions are TBBK (4.7%), BVS (3.4%) and HGV (3.3%). The top 20 holdings account for 44.22% of reported assets. Its disclosed equity book has returned +67.81% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
TBBK โ€” 6.2% ($77.67M)BVS โ€” 4.5% ($56.64M)HGV โ€” 4.3% ($54.11M)SVRA โ€” 3.4% ($42.98M)ETON โ€” 3.4% ($42.57M)AMRX โ€” 3.1% ($39.27M)EOLS โ€” 3.1% ($38.88M)AVTX โ€” 2.8% ($34.41M)LBRX โ€” 2.7% ($34.17M)AVR โ€” 2.7% ($33.33M)Other โ€” 63.6% ($794.22M)
36%in top 10
  • TBBK6.2%
  • BVS4.5%
  • HGV4.3%
  • SVRA3.4%
  • ETON3.4%
  • AMRX3.1%
  • EOLS3.1%
  • AVTX2.8%
  • LBRX2.7%
  • AVR2.7%
  • Other63.6%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
3
ADMAADMA BIOLOGICS INC1.2%
VORVOR BIOPHARMA INC0.9%
PLNTPLANET FITNESS MASTER ISSUER0.9%
Added to
15
AVTXAVALO THERAPEUTICS INC+50.8%
QUREUNIQURE NV+92.2%
FULCFULCRUM THERAPEUTICS INC+79.5%
ADCTADC THERAPEUTICS SA+120.2%
+11 more
Trimmed
21
ESTAESTABLISHMENT LABS HLDGS INC-59.7%
PTONPELOTON INTERACTIVE INC-57.4%
HGVHILTON GRAND VACATIONS INC-31.7%
TNGXTANGO THERAPEUTICS INC-60.0%
+17 more

Unlock alerts, watchlists & AI chat

Sign up free to track Nantahala Capital Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Nantahala Capital Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1472322). View Nantahala Capital Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all